USANA Health Sciences Inc. Hits New 52-Week High at $88.71 (USNA)
USANA Health Sciences (NASDAQ:USNA)’s share price reached a new 52-week high on Wednesday, Stock Ratings Network.com reports. The company traded as high as $88.71 and last traded at $88.16, with a volume of 57,369 shares traded. The stock had previously closed at $86.31.
A number of research firms have recently commented on USNA. Analysts at Janney Montgomery Scott raised their price target on shares of USANA Health Sciences (NASDAQ:USNA) from $49.00 to $72.00 in a research note to investors on Thursday, July 25th. They now have a “neutral” rating on the stock. Separately, analysts at Canaccord Genuity raised their price target on shares of USANA Health Sciences (NASDAQ:USNA) from $54.00 to $75.00 in a research note to investors on Wednesday, July 24th. Finally, analysts at DA Davidson reiterated a “neutral” rating on shares of USANA Health Sciences (NASDAQ:USNA) in a research note to investors on Wednesday, July 24th. They now have a $92.00 price target on the stock, up previously from $80.00.
Four research analysts have rated the stock with a hold rating, The company presently has a consensus rating of “Hold” and an average price target of $74.28.
In other USANA Health Sciences news, major shareholder Holdings Ltd Gull sold 7,000 shares of USANA Health Sciences stock on the open market in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $78.19, for a total transaction of $547,330.00. Following the completion of the transaction, the insider now directly owns 6,588,167 shares of the company’s stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.
USANA Health Sciences has a 52 week low of $30.51 and a 52 week high of $87.40. The stock’s 50-day moving average is $80. and its 200-day moving average is $66.16. The company has a market cap of $1.215 billion and a P/E ratio of 15.91.
USANA Health Sciences (NASDAQ:USNA) last released its earnings data on Tuesday, July 23rd. The company reported $1.72 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.33 by $0.39. The company had revenue of $189.10 million for the quarter, compared to the consensus estimate of $176.60 million. During the same quarter in the prior year, the company posted $1.11 earnings per share. The company’s quarterly revenue was up 17.5% on a year-over-year basis. Analysts expect that USANA Health Sciences will post $5.42 EPS for the current fiscal year.
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.